Zurueck zur Suche

Reporte zur Charge 004N20A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CT 1 TX 1

VAERS 2262818

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 004N20A

moderat
Staat
CT
Alter
76,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
13.01.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Biopsy Dizziness Dyspnoea Rash

Symptomtext

a little difficulty breathing; sometimes feels weakness; sometimes feels dizzy; rash all over his body that eventually got a little worse/ initially had a very unusual spreading rash all the way from his ankles to his neck that looked like dots or small pimples or lesions; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (a little difficulty breathing), ASTHENIA (sometimes feels weakness), DIZZINESS (sometimes feels dizzy) and RASH (rash all over his body that eventually got a little worse/ initially had a very unusual spreading rash all the way from his ankles to his neck that looked like dots or small pimples or lesions) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A, 004N20A and 004N20A) for COVID-19 vaccination. Patient had no allergies. Patient had never been diagnosed or tested positive for COVID-19. Previously administered products included for Product used for unknown indication: INFLUENZA VACCINE (Season Flu vaccine IM) in October 2021 and SHINGRIX. Past adverse reactions to the above products included No adverse event with INFLUENZA VACCINE and SHINGRIX. Concurrent medical conditions included Vision decreased (worsening). On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 07-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On an unknown date, the patient experienced DYSPNOEA (a little difficulty breathing), ASTHENIA (sometimes feels weakness), DIZZINESS (sometimes feels dizzy) and RASH (rash all over his body that eventually got a little worse/ initially had a very unusual spreading rash all the way from his ankles to his neck that looked like dots or small pimples or lesions). The patient was treated with TRIAMCINOLONE (topical) for Rash all over, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (a little difficulty breathing), ASTHENIA (sometimes feels weakness) and DIZZINESS (sometimes feels dizzy) had not resolved and RASH (rash all over his body that eventually got a little worse/ initially had a very unusual spreading rash all the way from his ankles to his neck that looked like dots or small pimples or lesions) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: no results from the biopsy was reported No results from the biopsy was reported and no results from the biopsy was reported No results from the biopsy was reported. No concomitant medication was reported. Patient stated that, patient went to a Medical Center for evaluation and was prescribed topical triamcinolone 0.1% cream and another unknown topical cream. However, the triamcinolone cream prescribed did not work. Patient stated, the rash has improved and was now on the legs and stomach only. Further patient jokingly stated that the patient sometimes had a little difficulty breathing and sometimes feels dizzy or weakness, but patient thinks that it was due to being older now. Patient has a dermatologist appointment scheduled for 02-May-2022 for another evaluation and opinion. The patient was prescribed with unknown topical cream.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Test Name: Biopsy; Result Unstructured Data: No results from the biopsy was reported; Test Name: Biopsy; Result Unstructured Data: No results from the biopsy was reported
Aktuelle Erkrankungen
Vision decreased (worsening)
Vorgeschichte
Comments: Patient had no allergies. Patient had never been diagnosed or tested positive for COVID-19.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1543272

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 004N20A

mild
Staat
TX
Alter
34,0
Geschlecht
F
Eingang
11.08.2021
Impfdatum
26.01.2021
Beginn
26.01.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Maternal exposure during pregnancy Myalgia Premature labour

Symptomtext

Preterm labor; Arm was a little bit sore; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PREMATURE LABOUR (Preterm labor), MYALGIA (Arm was a little bit sore) and MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004N20A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (allergy to Sulfa (not sure)). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in June 2020 and the estimated date of delivery was 23-Mar-2021. On 26-Jan-2021, the patient experienced MYALGIA (Arm was a little bit sore) and MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 29-Jan-2021, the patient experienced PREMATURE LABOUR (Preterm labor). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. On 26-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. At the time of the report, PREMATURE LABOUR (Preterm labor) and MYALGIA (Arm was a little bit sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment medication was not reported. Patient 32 weeks pregnant at the time of vaccination. Most recent FOLLOW-UP information incorporated above includes: On 26-Jan-2021: No specific follow-up information recorded.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myalgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Drug allergy (allergy to Sulfa (not sure))
Vorgeschichte
-
Andere Medikamente
PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS
Allergien
-
Vorherige Impfungen
-

VAERS 2527527

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 004N20A

mild
Staat
-
Alter
46,0
Geschlecht
F
Eingang
23.02.2021
Impfdatum
02.02.2021
Beginn
02.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Headache Injection site erythema Pain Rash

Symptomtext

Headache, Rash, body aches, chills Narrative: Pt reported body aches, headache, chills, rash from chin to neck/bck/chest/legs onset two wks after 1st dose vaccination (redness at injection site on 2/1/2021), but worse effects occurred after 2nd dose given on 2/2/21 listed. Pt required medical intervention. Pt was prescribed antibiotic, antihistamine and steroids (oral & injectable). Pt recovered. Pt did not supply specific medications taken for treatment. Other Relevant History:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-